{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:49:36Z","timestamp":1781246976216,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["BO 3361\/1-1 and 1-2"],"award-info":[{"award-number":["BO 3361\/1-1 and 1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["7-09-MN-54"],"award-info":[{"award-number":["7-09-MN-54"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U Prevention Center","award":["U01 DK078013-05S1"],"award-info":[{"award-number":["U01 DK078013-05S1"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jaut.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T20:15:26Z","timestamp":1371154526000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes"],"prefix":"10.1016","volume":"44","author":[{"given":"Tobias","family":"Boettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe P.","family":"Pagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zerhouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"von Herrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.05.002_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-3083.2005.01705.x","article-title":"Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope","volume":"63","author":"Alleva","year":"2006","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(85)91964-6","article-title":"Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus","volume":"1","author":"Assan","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(00)02579-4","article-title":"Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial","volume":"356","author":"Chaillous","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib6","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A\u00a0single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala\u2013Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.05.002_bib8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s001250051482","article-title":"No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group","volume":"43","author":"Pozzilli","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2013.05.002_bib10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(01)06801-5","article-title":"Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial","volume":"358","author":"Raz","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib11","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2337\/dc09-0373","article-title":"Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside","volume":"32","author":"Bresson","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2013.05.002_bib12","first-page":"305","article-title":"GABAergic cells and signals in CNS development","volume":"5","author":"Barker","year":"1998","journal-title":"Perspectives on Developmental Neurobiology"},{"key":"10.1016\/j.jaut.2013.05.002_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dmrr.941","article-title":"Therapy with GAD in diabetes","volume":"25","author":"Ludvigsson","year":"2009","journal-title":"Diabetes\/metabolism Research and Reviews"},{"key":"10.1016\/j.jaut.2013.05.002_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1126\/science.185693","article-title":"High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma","volume":"194","author":"Okada","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.05.002_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0140-6736(92)91061-C","article-title":"Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes","volume":"339","author":"Atkinson","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/298167a0","article-title":"Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins","volume":"298","author":"Baekkeskov","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.05.002_bib17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.46.11.1701","article-title":"Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers","volume":"46","author":"Bingley","year":"1997","journal-title":"Diabetes"},{"issue":"Suppl.","key":"10.1016\/j.jaut.2013.05.002_bib18","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0168-8227(96)90019-4","article-title":"Antibodies to glutamic acid decarboxylase in the prediction of insulin dependency","volume":"34","author":"Zimmet","year":"1996","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.jaut.2013.05.002_bib19","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/nm1296-1348","article-title":"Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice","volume":"2","author":"Tian","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/diabetes.47.6.894","article-title":"Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice","volume":"47","author":"Tisch","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.05.002_bib21","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa0804328","article-title":"GAD treatment and insulin secretion in recent-onset type 1 diabetes","volume":"359","author":"Ludvigsson","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1107096","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(11)60895-7","article-title":"Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial","volume":"378","author":"Wherrett","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.05.002_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model","volume":"1","author":"von Herrath","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.05.002_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mt.2009.197","article-title":"Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3\/GAD65 combination therapy in new-onset type 1 diabetes","volume":"18","author":"Bresson","year":"2010","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.jaut.2013.05.002_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.05.002_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.05.002_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.1996.tb21144.x","article-title":"Active suppression of diabetes after oral administration of insulin is determined by antigen dosage","volume":"778","author":"Bergerot","year":"1996","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jaut.2013.05.002_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2249.2003.02255.x","article-title":"Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes","volume":"134","author":"Petersen","year":"2003","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddmod.2009.03.008","article-title":"Mouse models for type 1 diabetes","volume":"6","author":"Van Belle","year":"2009","journal-title":"Drug Discovery Today Disease Models"},{"key":"10.1016\/j.jaut.2013.05.002_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dmrr.1126","article-title":"Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65)","volume":"26","author":"Axelsson","year":"2010","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1016\/j.jaut.2013.05.002_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2010.10.004","article-title":"GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients","volume":"138","author":"Hjorth","year":"2011","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib33","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.167.5.2950","article-title":"Plasmid vaccination with insulin B chain prevents autoimmune diabetes in nonobese diabetic mice","volume":"167","author":"Bot","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-7613(00)80121-1","article-title":"Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4\/Stat6 pathway","volume":"11","author":"Homann","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.05.002_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/84659","article-title":"Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses","volume":"7","author":"King","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/07853890008995930","article-title":"DNA vaccination to treat autoimmune diabetes","volume":"32","author":"von Herrath","year":"2000","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib37","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/db10-0630","article-title":"Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential","volume":"59","author":"Peakman","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.05.002_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2010.06.001","article-title":"GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response","volume":"137","author":"Cheramy","year":"2010","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-002-0806-9","article-title":"Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase","volume":"45","author":"Jun","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2013.05.002_bib40","doi-asserted-by":"crossref","first-page":"e25337","DOI":"10.1371\/journal.pone.0025337","article-title":"Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ss-cells in diabetic NOD mice","volume":"6","author":"Tian","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2013.05.002_bib41","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/diabetes.49.8.1301","article-title":"1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1\/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524\u2013543)","volume":"49","author":"Overbergh","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.05.002_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.beem.2011.04.009","article-title":"Vitamin D in autoimmune, infectious and allergic diseases: a vital player?","volume":"25","author":"Van Belle","year":"2011","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.jaut.2013.05.002_bib43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.183.4.1561","article-title":"Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes","volume":"183","author":"Tian","year":"1996","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.jaut.2013.05.002_bib44","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.163.3.1178","article-title":"Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent","volume":"163","author":"Tisch","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.jaut.2013.05.002_bib45","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.vaccine.2010.04.005","article-title":"Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism","volume":"28","author":"Gong","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2013.05.002_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2009.01.001","article-title":"Induction of anti-whole GAD65 reactivity in\u00a0vivo results in disease suppression in type 1 diabetes","volume":"32","author":"Kanazawa","year":"2009","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.jaut.2013.05.002_bib47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaut.2012.04.005","article-title":"Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading","volume":"39","author":"Prasad","year":"2012","journal-title":"Journal of Autoimmunity"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684111300070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684111300070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:33Z","timestamp":1760256393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684111300070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":47,"alternative-id":["S089684111300070X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.05.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}